Employers have the opportunity to lead by example: to stop treating obesity as invisible and start addressing it as the ...

The findings add to other research showing a lower risk of obesity-related cancers in patients taking GLP-1 drugs, a class of ...

When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being ...

Risk of heart failure (HF) has been shown to increase as body mass index (BMI) increases; however, BMI has limitations as an obesity measure. Over median follow-up of 13 years, waist-to-height ratio ...

The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...

Three notes: The overall incidence of obesity-related cancers was similar between the GLP-1 and bariatric surgery groups — about 5 to 6 cases per 1,000 person-years — despite the fact that ...

US News has weighed in on America’s ever-expanding waistline, ranking the country’s most obese states — and the results may ...

retrospective cohort study based on electronic medical records data to compare the incidence of ORC in adults (≥24 years) living with obesity and diabetes who were treated with a first ...